Does Sackett Foreshadow the End of Non-Reviewability for FDA Warning Letters?
Does Sackett Foreshadow the End of Non-Reviewability for FDA Warning Letters?
About this item
Full title
Author / Creator
Publisher
United States: Food and Drug Law Institute (FDLI)
Journal title
Language
English
Formats
Publication information
Publisher
United States: Food and Drug Law Institute (FDLI)
Subjects
More information
Scope and Contents
Contents
FDA warning letters are considered non-final agency actions and thus are not subject to judicial review under the Administrative Procedure Act (APA). The Supreme Court’s analysis in Sackett v. EPA suggests the legal tides might be shifting. In Sackett, the Court held that an Environmental Protection Agency (EPA) compliance order was considered fina...
Alternative Titles
Full title
Does Sackett Foreshadow the End of Non-Reviewability for FDA Warning Letters?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1508956232
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1508956232
Other Identifiers
ISSN
1064-590X
